392 related articles for article (PubMed ID: 20645852)
21. Non-alcoholic fatty liver disease and the metabolic syndrome: an update.
Rector RS; Thyfault JP; Wei Y; Ibdah JA
World J Gastroenterol; 2008 Jan; 14(2):185-92. PubMed ID: 18186553
[TBL] [Abstract][Full Text] [Related]
22. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
23. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.
Lim JS; Mietus-Snyder M; Valente A; Schwarz JM; Lustig RH
Nat Rev Gastroenterol Hepatol; 2010 May; 7(5):251-64. PubMed ID: 20368739
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
Manco M
J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
[TBL] [Abstract][Full Text] [Related]
25. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
[TBL] [Abstract][Full Text] [Related]
26. Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux.
Otero YF; Stafford JM; McGuinness OP
J Biol Chem; 2014 Jul; 289(30):20462-9. PubMed ID: 24907277
[TBL] [Abstract][Full Text] [Related]
27. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
[TBL] [Abstract][Full Text] [Related]
28. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.
Qureshi K; Abrams GA
World J Gastroenterol; 2007 Jul; 13(26):3540-53. PubMed ID: 17659704
[TBL] [Abstract][Full Text] [Related]
29. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
DeFronzo RA; Ferrannini E
Diabetes Care; 1991 Mar; 14(3):173-94. PubMed ID: 2044434
[TBL] [Abstract][Full Text] [Related]
30. Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance.
Savage DB; Semple RK
Curr Opin Lipidol; 2010 Aug; 21(4):329-36. PubMed ID: 20581678
[TBL] [Abstract][Full Text] [Related]
31. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice.
Osei-Hyiaman D; Liu J; Zhou L; Godlewski G; Harvey-White J; Jeong WI; Bátkai S; Marsicano G; Lutz B; Buettner C; Kunos G
J Clin Invest; 2008 Sep; 118(9):3160-9. PubMed ID: 18677409
[TBL] [Abstract][Full Text] [Related]
32. The metabolic abnormalities associated with non-alcoholic fatty liver disease.
Haque M; Sanyal AJ
Best Pract Res Clin Gastroenterol; 2002 Oct; 16(5):709-31. PubMed ID: 12406441
[TBL] [Abstract][Full Text] [Related]
33. Estrogen and voluntary exercise attenuate cardiometabolic syndrome and hepatic steatosis in ovariectomized rats fed a high-fat high-fructose diet.
Buniam J; Chukijrungroat N; Khamphaya T; Weerachayaphorn J; Saengsirisuwan V
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E908-E921. PubMed ID: 30807216
[TBL] [Abstract][Full Text] [Related]
34. Insulin resistance and the metabolic syndrome.
Lann D; Gallagher E; Leroith D
Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723
[TBL] [Abstract][Full Text] [Related]
35. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
36. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
[TBL] [Abstract][Full Text] [Related]
37. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
38. Metabolic inflexibility in skeletal muscle: a prelude to the cardiometabolic syndrome?
Thyfault JP; Rector RS; Noland RC
J Cardiometab Syndr; 2006; 1(3):184-9. PubMed ID: 17679820
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M; Jornayvaz FR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
[TBL] [Abstract][Full Text] [Related]
40. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
Rametta R; Ruscica M; Dongiovanni P; Macchi C; Fracanzani AL; Steffani L; Fargion S; Magni P; Valenti L
Eur J Clin Invest; 2014 Jul; 44(7):627-33. PubMed ID: 24828988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
